Medical School · Year 3 · Neurology · includes a quiz and discussion video

Seminar 15: Neurocritical Care

Neurology Clerkship

Learning Objectives

By the end of this seminar, students will be able to:

1. Assess neurological status in critically ill patients
2. Manage elevated intracranial pressure
3. Recognize and treat brain herniation syndromes
4. Apply neuroprotective strategies in brain injury
5. Monitor for and manage seizures in the ICU
6. Determine prognosis and apply principles of brain death evaluation

Seminar Outline

Section 1: Neurological Assessment in the ICU

The Glasgow Coma Scale is the most widely used standardized tool for assessing the level of consciousness in critically ill neurological patients and is composed of three independently scored components that together provide a quantitative measure of responsiveness. The eye-opening component is scored from 1 to 4, with spontaneous eye opening receiving a score of 4, eye opening to verbal command scoring 3, eye opening to painful stimulation scoring 2, and no eye opening scoring 1. The verbal component ranges from 1 to 5, with oriented speech scoring 5, confused but intelligible speech scoring 4, recognizable but inappropriate words scoring 3, incomprehensible sounds scoring 2, and no verbal output scoring 1. The motor component ranges from 1 to 6, with obedience to commands scoring 6, localization to painful stimuli scoring 5, withdrawal from pain scoring 4, abnormal flexion posturing scoring 3, extension posturing scoring 2, and no motor response scoring 1. The total score ranges from 3 to 15, and a GCS score of 8 or less defines severe traumatic brain injury and is the threshold at which endotracheal intubation is generally indicated to protect the airway.

Pupillary examination is a critical component of the ICU neurological assessment because changes in pupil size and reactivity provide immediate, real-time information about brainstem function and impending herniation. Equal and reactive pupils indicate normal parasympathetic innervation through the oculomotor nerve and are a reassuring finding. A unilateral dilated, fixed pupil is the hallmark of ipsilateral third cranial nerve compression, most commonly resulting from uncal herniation, and demands immediate intervention to prevent irreversible brainstem damage. Bilateral dilated, fixed pupils indicate severe bilateral brainstem injury and carry a grave prognosis. Pinpoint pupils suggest either a pontine lesion, which destroys the descending sympathetic pathways, or the effects of opioid medications, a distinction that can be clarified by administering naloxone. Midposition fixed pupils, typically measuring 4 to 6 millimeters, indicate a midbrain lesion that has disrupted both the sympathetic dilating and parasympathetic constricting pathways at their midbrain convergence.

The structured examination of the comatose patient extends beyond the Glasgow Coma Scale to include a comprehensive assessment of brainstem function, motor responses, and respiratory patterns. Brainstem reflexes are systematically tested, including the pupillary light reflex, the corneal reflex, the oculocephalic reflex (doll's eyes), and the gag reflex, with progressive loss of these reflexes indicating rostral-to-caudal brainstem deterioration. The best motor response to a standardized painful stimulus, such as nail bed pressure or trapezius squeeze, provides critical information about the depth of coma and helps localize the level of neurological impairment. Respiratory patterns carry localizing significance, with Cheyne-Stokes respiration suggesting bilateral cerebral or upper brainstem dysfunction, central neurogenic hyperventilation suggesting midbrain or upper pontine injury, and ataxic or irregular breathing indicating medullary dysfunction. The presence of posturing responses has particularly important prognostic implications, with decorticate posturing, consisting of upper extremity flexion and lower extremity extension, indicating dysfunction at the level of the cerebral hemispheres or internal capsule, and decerebrate posturing, consisting of extension of all four extremities, indicating a deeper injury at the level of the midbrain or upper pons.

The Full Outline of UnResponsiveness, or FOUR score, was developed as an alternative to the Glasgow Coma Scale that addresses several of its limitations. The FOUR score evaluates four components, each scored from 0 to 4: eye response, motor response, brainstem reflexes, and respiration. The inclusion of brainstem reflexes as a separate component allows more nuanced assessment of posterior fossa function than is possible with the GCS alone. The respiratory component enables the FOUR score to be applied to intubated patients, who cannot be assessed for verbal responses on the GCS, providing a distinct advantage in the ICU setting where many patients are mechanically ventilated. The maximum score on the FOUR scale is 16, and the scoring system provides more granular differentiation among patients at the lower end of consciousness, which is particularly valuable in the neurocritical care setting.

<image>ICU neurological assessment: GCS, pupils, coma exam, FOUR score</image>

Section 2: Intracranial Pressure Management

The normal intracranial pressure in adults ranges from 5 to 15 mmHg and is determined by the interaction of three intracranial compartments as described by the Monro-Kellie doctrine: the brain parenchyma, the cerebrospinal fluid, and the intracranial blood volume together occupy a fixed volume within the rigid skull, and any increase in one compartment must be compensated by a decrease in another, or intracranial pressure will rise. Cerebral perfusion pressure, calculated as the mean arterial pressure minus the intracranial pressure, represents the driving pressure gradient for cerebral blood flow and must be maintained at a target of 60 to 70 mmHg to ensure adequate oxygen and nutrient delivery to the brain. When compensatory mechanisms are exhausted and intracranial pressure rises beyond normal limits, the resulting impairment of cerebral perfusion and the mechanical effects of brain displacement can produce devastating and irreversible neurological injury.

Elevated intracranial pressure produces a recognizable constellation of clinical and radiographic findings that the clinician must identify promptly. Clinical signs include headache, which is often the earliest symptom, nausea and vomiting reflecting stimulation of the area postrema, and papilledema detected on fundoscopic examination representing optic nerve sheath distension from transmitted cerebrospinal fluid pressure. The Cushing triad, consisting of hypertension, bradycardia, and irregular respirations, is a late and ominous sign indicating severe brainstem compression that demands immediate intervention. Progressive decline in the level of consciousness is the most important clinical indicator and may precede other signs. Radiographic findings on CT or MRI include midline shift of brain structures, effacement or compression of the cerebral ventricles, loss of the normal cortical sulcal pattern, signs of uncal herniation with medial temporal lobe displacement, and hydrocephalus from obstruction of cerebrospinal fluid pathways.

Monitoring of intracranial pressure is indicated in patients who cannot be reliably assessed by clinical examination alone, most commonly those with severe traumatic brain injury. The external ventricular drain, or EVD, is the gold standard monitoring device because it simultaneously provides continuous, accurate intracranial pressure measurement and allows therapeutic drainage of cerebrospinal fluid to reduce pressure. Intraparenchymal pressure monitors provide accurate continuous measurement but lack the ability to drain cerebrospinal fluid. The primary indications for ICP monitoring include a GCS score of 8 or less with an abnormal CT scan in the setting of severe traumatic brain injury, situations in which serial neurological examinations are unreliable due to sedation or pharmacological paralysis, and selected cases of subarachnoid hemorrhage, intracerebral hemorrhage, or acute hydrocephalus.

The management of elevated intracranial pressure follows a stepwise, tiered approach that escalates from general measures through increasingly aggressive interventions. General measures include elevation of the head of bed to 30 degrees to promote venous drainage from the cranial cavity, avoidance of hypercarbia by maintaining adequate ventilation since elevated carbon dioxide causes cerebral vasodilation and increases intracranial blood volume, and aggressive treatment of fever since hyperthermia increases cerebral metabolic rate and exacerbates intracranial hypertension. First-tier interventions include adequate sedation and analgesia to reduce cerebral metabolic demand and prevent agitation-related ICP spikes, along with osmotic therapy with mannitol or hypertonic saline. Second-tier interventions include cerebrospinal fluid drainage through an external ventricular drain and brief hyperventilation to achieve a PCO2 of 30 to 35 mmHg, which reduces intracranial blood volume through cerebral vasoconstriction but must be used judiciously because prolonged hyperventilation can cause cerebral ischemia. Third-tier interventions, reserved for refractory intracranial hypertension, include decompressive craniectomy, in which a large bone flap is removed to allow the swollen brain to expand outward, and barbiturate coma, which profoundly suppresses cerebral metabolism.

<image>ICP management: physiology, signs, monitoring, stepwise treatment</image>

Section 3: Osmotic Therapy

Mannitol is an osmotic agent that has been used for decades in the management of elevated intracranial pressure and cerebral edema. It is administered as an intravenous bolus at a dose of 0.25 to 1 gram per kilogram, with onset of action occurring within 15 to 30 minutes and a duration of effect lasting approximately 4 to 6 hours. Mannitol reduces intracranial pressure through two mechanisms: it creates an osmotic gradient across the blood-brain barrier that draws water from the brain parenchyma into the intravascular space, and it has rheological effects that reduce blood viscosity and improve cerebral blood flow, triggering autoregulatory vasoconstriction that further reduces intracranial blood volume. Monitoring of serum osmolality is essential during mannitol therapy, with a target of keeping the osmolality below 320 mOsm/kg to avoid renal toxicity; hypotension must be avoided because mannitol's diuretic effect can lead to significant volume depletion. Mannitol is contraindicated in hypovolemic patients and those with renal failure, as it requires renal excretion and can exacerbate both conditions.

Hypertonic saline has become an increasingly used alternative to mannitol for the treatment of elevated intracranial pressure. It is available in multiple concentrations, including 3%, 7.5%, and 23.4%, with dosing dependent on the concentration used: 3% hypertonic saline is typically administered as 250 to 500 milliliters, while 23.4% saline is given as a 30-milliliter bolus for acute, life-threatening herniation. The target serum sodium during hypertonic saline therapy is 145 to 155 mEq/L, with regular monitoring to ensure this range is maintained. The primary advantage of hypertonic saline over mannitol is that it does not produce an osmotic diuresis and therefore maintains or expands intravascular volume, making it a better choice in hemodynamically unstable patients. Serum sodium must be monitored frequently, and high concentrations, particularly 23.4%, require central venous access to prevent phlebitis and tissue necrosis from peripheral extravasation.

The choice between mannitol and hypertonic saline depends on the clinical context and the patient's hemodynamic status. Mannitol produces diuresis and may deplete intravascular volume, while hypertonic saline maintains or expands the circulating volume, making it preferable in patients with borderline or low blood pressure. Mannitol can worsen renal function, particularly with repeated dosing, whereas hypertonic saline generally preserves renal function. Mannitol can be administered through a peripheral intravenous line, whereas the highest concentrations of hypertonic saline require central venous access. Monitoring differs between the two agents: mannitol therapy is guided by the serum osmolality and the osmolality gap, while hypertonic saline therapy is monitored by following the serum sodium level.

Both osmotic agents carry the risk of complications that must be anticipated and managed. Rebound cerebral edema can occur when osmotic therapy is discontinued abruptly, as the osmotic gradient reverses and water shifts back into the brain parenchyma, necessitating gradual withdrawal of these agents. Electrolyte imbalances, including hyponatremia or hypernatremia depending on the agent used, require close monitoring and correction. Volume depletion is a specific risk of mannitol therapy and must be addressed with concurrent fluid replacement to maintain adequate cerebral perfusion pressure. Central pontine myelinolysis, a devastating osmotic demyelination syndrome, can result from overly rapid changes in serum sodium concentration in either direction, underscoring the critical importance of controlled, gradual sodium adjustments.

<image>Osmotic therapy: mannitol, hypertonic saline, comparison, complications</image>

Section 4: Herniation Syndromes

Uncal herniation is the most clinically important herniation syndrome and occurs when an expanding supratentorial mass lesion forces the medial temporal lobe, specifically the uncus, through the tentorial incisura, compressing the adjacent structures. The earliest clinical sign is typically an ipsilateral dilated pupil from compression of the parasympathetic fibers running along the surface of the third cranial nerve, followed by contralateral hemiparesis from compression of the ipsilateral cerebral peduncle against the tentorium. The Kernohan notch phenomenon is an important false localizing sign in which the opposite cerebral peduncle is compressed against the contralateral tentorial edge, producing ipsilateral hemiparesis that can mislead the clinician into localizing the lesion to the wrong side. If unchecked, uncal herniation progresses to bilateral third nerve involvement with bilateral fixed, dilated pupils, and subsequently to complete brainstem compression with loss of all brainstem reflexes.

Central or transtentorial herniation occurs when bilateral or diffuse supratentorial pathology produces a symmetric downward displacement of the diencephalon and brainstem through the tentorial notch, and it progresses through recognizable clinical stages. In the early diencephalic stage, the pupils are small but reactive, the respiratory pattern is Cheyne-Stokes, and the motor response is decorticate posturing with upper extremity flexion. As the herniation progresses to involve the midbrain, the pupils become midposition and fixed, the motor response transitions to decerebrate posturing with extension, and the respiratory pattern becomes irregular. In the terminal stage, the pupils are bilaterally dilated and fixed, the patient is flaccid with no motor responses, and respiration ceases, indicating complete loss of brainstem function.

Several other herniation patterns are recognized, each with characteristic clinical features determined by the direction of brain displacement and the structures compressed. Subfalcine herniation occurs when the cingulate gyrus is displaced under the falx cerebri by a unilateral hemispheric mass, and compression of the anterior cerebral artery can produce infarction of the medial frontal lobe, manifesting as contralateral leg weakness. Tonsillar herniation involves descent of the cerebellar tonsils through the foramen magnum, directly compressing the medulla and producing sudden respiratory arrest, making it the most immediately life-threatening herniation pattern. Upward herniation occurs when a posterior fossa mass forces the cerebellum upward through the tentorial notch, compressing the midbrain from below. External herniation describes displacement of brain tissue through a skull defect, which may be a traumatic fracture or a prior surgical craniectomy site.

The emergent management of brain herniation requires rapid, coordinated interventions aimed at reducing intracranial pressure and preventing irreversible brainstem damage. The head of bed should be elevated to 30 degrees to promote venous drainage and reduce intracranial blood volume. Brief hyperventilation to achieve a PCO2 of 30 to 35 mmHg provides rapid though temporary reduction in intracranial pressure through cerebral vasoconstriction. An immediate bolus of osmotic therapy, either mannitol or hypertonic saline, should be administered to create an osmotic gradient that draws water out of the brain parenchyma. Sedation reduces cerebral metabolic demand and can lower intracranial pressure by eliminating agitation and its associated hemodynamic surges. Emergent surgical decompression, whether evacuation of a hematoma or decompressive craniectomy, should be pursued when indicated, as definitive surgical treatment of the underlying cause is often the most effective intervention for herniation.

<image>Herniation: uncal, central, other types, emergent management</image>

Section 5: Severe Traumatic Brain Injury

Traumatic brain injury is classified by severity based on the initial Glasgow Coma Scale score obtained after resuscitation. Mild traumatic brain injury is defined by a GCS score of 13 to 15, moderate traumatic brain injury by a GCS score of 9 to 12, and severe traumatic brain injury by a GCS score of 8 or less. This classification system provides immediate prognostic information and guides the intensity of monitoring and treatment, with severe traumatic brain injury requiring ICU admission, invasive monitoring, and aggressive neuroprotective management.

The initial management of severe traumatic brain injury follows a systematic approach that prioritizes prevention of secondary brain injury. Endotracheal intubation should be performed in all patients with a GCS of 8 or less to secure the airway and prevent aspiration, which is a major cause of preventable morbidity. Hypotension, defined as systolic blood pressure below 90 mmHg, must be aggressively avoided because even a single episode of hypotension in the setting of severe traumatic brain injury is associated with a significant increase in mortality and poor neurological outcomes. Hypoxia, defined as oxygen saturation below 90%, must similarly be prevented through supplemental oxygen and mechanical ventilation. Immediate CT imaging of the head should be performed to identify surgically treatable lesions such as epidural and subdural hematomas. Neurosurgical consultation should be obtained urgently for any patient with an operative lesion on CT or clinical evidence of neurological deterioration.

Neuroprotective management of severe traumatic brain injury targets several physiological parameters that have been shown to influence outcomes. Intracranial pressure should be maintained below 22 mmHg, with escalating interventions as needed to achieve this target. Cerebral perfusion pressure should be maintained between 60 and 70 mmHg to ensure adequate cerebral blood flow without the risks of excessive perfusion, which can worsen vasogenic edema. Blood pressure targets are age-dependent, with systolic blood pressure maintained above 100 mmHg for patients aged 50 to 69 years and above 110 mmHg for those aged 15 to 49 years and those over 70 years. Blood glucose should be maintained between 140 and 180 mg/dL, avoiding both hyperglycemia, which exacerbates secondary brain injury, and hypoglycemia, which deprives the injured brain of its primary energy substrate. Normothermia should be actively maintained and fever aggressively treated, as hyperthermia increases cerebral metabolic rate and worsens secondary injury. Serum sodium is maintained in the range of 140 to 155 mEq/L, reflecting the use of hypertonic saline as part of ICP management.

Surgical intervention for traumatic intracranial lesions is guided by established criteria based on the size, mass effect, and clinical impact of each lesion type. Epidural hematoma warrants surgical evacuation when the thickness exceeds 15 millimeters or the volume exceeds 30 milliliters, and emergent craniotomy for epidural hematoma evacuation is one of the most time-critical neurosurgical procedures. Acute subdural hematoma requires evacuation when the thickness exceeds 10 millimeters, the midline shift exceeds 5 millimeters, or the patient demonstrates a decline in GCS score attributable to the hematoma. Depressed skull fractures require surgical elevation when the bone fragment is depressed more than the full thickness of the adjacent skull table. Posterior fossa lesions carry a lower threshold for surgical evacuation due to the limited volume of the posterior fossa and the risk of rapid brainstem compression and tonsillar herniation.

<image>Severe TBI: classification, initial management, targets, surgery</image>

Section 6: Subarachnoid Hemorrhage

Subarachnoid hemorrhage from a ruptured intracranial aneurysm presents with a characteristic clinical syndrome that demands immediate recognition and urgent intervention. The hallmark symptom is a sudden, severe headache frequently described by patients as the "worst headache of my life," reaching maximum intensity within seconds and representing one of the most dramatic and recognizable presentations in neurology. Meningismus, manifesting as neck stiffness and photophobia, develops as the blood in the subarachnoid space irritates the meninges. The level of consciousness is variable, ranging from normal alertness to deep coma depending on the severity of the hemorrhage and the extent of associated brain injury. A third cranial nerve palsy with a dilated, poorly reactive pupil may be present, indicating compression of the oculomotor nerve by an expanding or ruptured posterior communicating artery aneurysm. Seizures may occur at the time of hemorrhage onset and add to the secondary brain injury.

The Hunt and Hess grading scale provides a standardized assessment of clinical severity in subarachnoid hemorrhage and strongly predicts outcome. Grade 1 describes a patient who is asymptomatic or has only mild headache. Grade 2 describes moderate to severe headache with nuchal rigidity but no neurological deficit other than cranial nerve palsy. Grade 3 describes a patient who is drowsy or confused with a mild focal neurological deficit. Grade 4 describes stupor with moderate to severe hemiparesis. Grade 5 describes a patient in deep coma with decerebrate posturing. Higher grades are associated with progressively worse surgical outcomes and overall mortality, and the clinical grade at presentation is one of the most important determinants of prognosis.

The management priorities in subarachnoid hemorrhage center on preventing the major complications that drive morbidity and mortality. Securing the ruptured aneurysm, either by surgical clipping or endovascular coiling, should be accomplished within 24 to 72 hours of hemorrhage to eliminate the risk of rebleeding, which carries a mortality rate exceeding 50 percent. Blood pressure is managed to maintain systolic blood pressure below 160 mmHg before the aneurysm is secured to reduce the rebleeding risk, with higher targets permissible after definitive treatment. Nimodipine, a calcium channel blocker, is administered at a dose of 60 milligrams every 4 hours for 21 days and has been shown to improve outcomes after subarachnoid hemorrhage, likely through its neuroprotective effects rather than direct prevention of large-vessel vasospasm. Maintenance of euvolemia is essential, as both hypovolemia and excessive fluid loading can worsen outcomes. Short-term seizure prophylaxis is sometimes employed, though its routine use remains controversial.

Subarachnoid hemorrhage is complicated by several delayed complications that require vigilant monitoring and proactive management. Rebleeding occurs most commonly in the first hours to days after the initial hemorrhage and is the strongest argument for early aneurysm securing. Vasospasm, the pathological narrowing of cerebral arteries caused by the irritant effects of subarachnoid blood, typically occurs between days 3 and 14 after hemorrhage and is monitored using transcranial Doppler ultrasonography; treatment includes hemodynamic augmentation with hypertension, hypervolemia, and hemodilution (HHH therapy), along with endovascular balloon angioplasty or intra-arterial vasodilator infusion for refractory cases. Hydrocephalus can develop acutely from obstruction of cerebrospinal fluid pathways by blood in the ventricles, requiring emergent external ventricular drainage, or can develop in a delayed fashion requiring permanent ventriculoperitoneal shunting. Hyponatremia occurring between days 3 and 14 may result from the syndrome of inappropriate antidiuretic hormone secretion or from cerebral salt wasting, and distinguishing between these two entities has important treatment implications. Seizures may occur in the acute phase or develop as a delayed complication.

<image>SAH: presentation, grading, management, complications</image>

Section 7: Status Epilepticus in the ICU

Status epilepticus is defined by its temporal characteristics and response to treatment, with several important subtypes that carry different clinical implications. Convulsive status epilepticus is defined as five or more minutes of continuous seizure activity or two or more seizures without return to baseline consciousness between episodes. Non-convulsive status epilepticus represents ongoing electrographic seizure activity without prominent motor convulsions, manifesting instead as persistent alteration of consciousness. Refractory status epilepticus is defined by the failure of seizures to terminate despite the administration of two appropriately dosed first-line and second-line antiepileptic medications. Super-refractory status epilepticus is defined as seizure activity that persists for 24 hours or more despite the initiation of continuous intravenous anesthetic infusions.

The treatment of status epilepticus follows a time-sensitive, staged protocol that escalates rapidly through progressively more aggressive interventions. In the initial phase, from 0 to 5 minutes, a benzodiazepine is administered as the first-line agent, with intravenous lorazepam at a dose of 4 milligrams or intramuscular midazolam at 10 milligrams being the preferred options. In the second phase, from 5 to 20 minutes, if seizures persist, a second-line antiepileptic drug is administered intravenously, with the three recommended options being fosphenytoin, valproate, or levetiracetam. In the third phase, from 20 to 40 minutes, if seizures continue, a repeat dose of a second-line agent or escalation to anesthetic therapy is indicated. For refractory status epilepticus persisting beyond 40 minutes, continuous intravenous infusions of propofol, midazolam, or pentobarbital are initiated, with continuous EEG monitoring to guide titration to a goal of burst-suppression or electrographic seizure cessation.

Non-convulsive status epilepticus is a critically important entity in the ICU setting because it is common, often missed, and associated with significant morbidity. The clinical presentation is typically that of an unexplained altered mental status without the dramatic motor manifestations that characterize convulsive seizures, making it invisible to the untrained observer. Risk factors include a prior history of seizures, critical illness, and acute central nervous system injury from any cause, including stroke, traumatic brain injury, and intracranial surgery. Diagnosis requires continuous EEG monitoring, which is the only means of detecting the ongoing electrographic seizure activity. The importance of recognizing non-convulsive status epilepticus cannot be overstated, as it is common among ICU patients with unexplained encephalopathy and, if left untreated, causes ongoing neuronal injury and worsens outcomes.

Continuous EEG monitoring has become an essential tool in the neurocritical care unit and is indicated in several clinical scenarios. Any ICU patient with unexplained altered mental status should undergo continuous EEG monitoring to rule out non-convulsive status epilepticus as the cause. Following treatment of convulsive status epilepticus, continuous EEG is necessary to confirm that electrographic seizure activity has ceased, as motor manifestations may resolve while subclinical seizures continue. In comatose patients, continuous EEG monitoring can detect seizures, help with prognostication through assessment of background activity and reactivity, and guide therapeutic decision-making. During targeted temperature management protocols after cardiac arrest, continuous EEG monitoring is performed to detect seizures, which are common during both the cooling and rewarming phases.

<image>Status epilepticus: definitions, protocol, NCSE, ICU EEG</image>

Section 8: Anoxic Brain Injury

Anoxic brain injury results from global cerebral ischemia, most commonly following cardiac arrest or severe sustained hypotension, and represents one of the most devastating neurological injuries encountered in clinical practice. The brain is exquisitely sensitive to oxygen deprivation, with irreversible neuronal injury beginning within minutes of complete ischemia. Certain brain regions exhibit selective vulnerability to hypoxic-ischemic injury, with the hippocampus, cerebral cortex, and cerebellum being disproportionately affected due to their high metabolic rates and the characteristics of their vascular supply. Secondary injury mechanisms, including reperfusion injury and inflammatory cascades that are activated when blood flow is restored, compound the initial ischemic insult and can extend the zone of neuronal death beyond that caused by the primary event.

Targeted temperature management is the cornerstone of neuroprotective therapy for comatose patients following cardiac arrest. The indication for targeted temperature management is a patient who remains comatose after return of spontaneous circulation following cardiac arrest. The current evidence supports maintaining a target temperature between 32 and 36 degrees Celsius for 24 hours, followed by active avoidance of fever for at least 72 hours, as even mild hyperthermia during this period can exacerbate brain injury. The rewarming phase must be conducted slowly, at a rate no faster than 0.25 degrees Celsius per hour, to prevent the rebound cerebral edema and hemodynamic instability that can occur with rapid rewarming.

Prognostication after anoxic brain injury is one of the most consequential clinical assessments in medicine and must be approached with appropriate caution and rigor to avoid premature withdrawal of care in patients who might otherwise recover. The cardinal rule is to wait at least 72 hours after rewarming before making prognostic determinations, as earlier assessments are confounded by residual effects of hypothermia, sedation, and metabolic derangements. A multimodal approach that combines multiple independent predictors is essential, as no single test is sufficiently reliable in isolation. All prognostic assessments must account for potential confounders, including the residual effects of sedation, the physiological effects of hypothermia and rewarming, and concurrent metabolic abnormalities.

Several specific findings, when assessed at the appropriate time and in the absence of confounders, are associated with poor neurological prognosis after anoxic brain injury. On clinical examination performed at least 72 hours after the arrest, the absence of pupillary and corneal reflexes, and a motor response of extensor posturing or no response, are strongly associated with poor outcome. Electroencephalographic findings associated with poor prognosis include a burst-suppression pattern and an unreactive background, both indicating severe, widespread cortical dysfunction. Somatosensory evoked potentials demonstrating bilateral absence of the cortical N20 waveform indicate severe disruption of the thalamocortical sensory pathway and are one of the most reliable predictors of poor outcome. Brain MRI demonstrating extensive cortical diffusion restriction indicates widespread irreversible cortical injury. Neuron-specific enolase, a biomarker of neuronal injury, when markedly elevated to levels exceeding 33 to 67 micrograms per liter, is associated with poor prognosis, though specific thresholds vary by assay and clinical context.

<image>Anoxic brain injury: pathophysiology, TTM, prognostication</image>

Section 9: Brain Death

The determination of brain death requires that several prerequisites are met before the clinical examination can proceed, ensuring that the clinical findings genuinely represent irreversible loss of brain function rather than potentially reversible conditions. The patient must be in a coma with a known, irreversible cause that is sufficient to explain the clinical findings. Normothermia must be established, with a core body temperature of at least 36 degrees Celsius, because hypothermia can profoundly suppress neurological function and mimic brain death. Normotension, defined as a systolic blood pressure of at least 100 mmHg, must be ensured because hypotension can impair brainstem perfusion and produce findings that mimic irreversible brain death. All potential confounders must be excluded, including residual effects of sedative medications, neuromuscular blocking agents, and severe metabolic derangements such as hepatic encephalopathy or uremia.

The clinical examination for brain death requires the demonstration of absent brainstem reflexes and absent motor responses to painful stimulation. The pupillary light reflex must be absent bilaterally, with pupils fixed in a dilated or midposition. The corneal reflex must be absent bilaterally when the cornea is directly stimulated. The oculocephalic reflex, or doll's eyes, must be absent, with the eyes remaining fixed in the midline during head turning, provided cervical spine injury has been excluded. The oculovestibular reflex, tested by irrigating the ear canal with cold water, must produce no eye movement. The gag reflex must be absent when the posterior pharynx is stimulated. The cough reflex must be absent when a suction catheter is passed into the trachea. There must be no motor response to standardized painful stimulation applied to any area innervated by cranial or spinal nerves, though spinal-mediated reflexes may persist and do not preclude a diagnosis of brain death.

The apnea test is the final and most critical component of the brain death examination, designed to determine whether any respiratory drive remains. Preoxygenation with 100% FiO2 for 10 minutes ensures adequate oxygen reserves to prevent hypoxia during the test. The patient is then disconnected from the mechanical ventilator while oxygen is delivered passively through a cannula placed in the endotracheal tube. The patient is observed for 8 to 10 minutes for any spontaneous respiratory effort while arterial blood gases are monitored. The test is considered positive for brain death, meaning it supports the diagnosis, when the PCO2 rises to 60 mmHg or more, or rises 20 mmHg or more above the baseline level, without any observed respiratory effort, confirming the absence of brainstem-mediated respiratory drive.

Ancillary tests are used to confirm brain death when the complete clinical examination, including the apnea test, cannot be performed due to confounding factors or medical instability. Cerebral angiography is considered the gold standard ancillary test and demonstrates the absence of intracranial blood flow. Electroencephalography demonstrates electrocerebral silence, defined as the absence of any cerebral electrical activity at standard and high sensitivity settings. Radionuclide cerebral perfusion scanning demonstrates the absence of cerebral isotope uptake, producing the characteristic "hollow skull" appearance. Transcranial Doppler ultrasonography demonstrates reverberating flow patterns or small systolic peaks without diastolic flow, indicating the absence of effective intracranial perfusion. Ancillary testing is specifically indicated when the clinical examination cannot be completed, such as when facial trauma prevents assessment of certain brainstem reflexes, severe pulmonary disease prevents a valid apnea test, or confounding medications cannot be fully excluded.

<image>Brain death: prerequisites, clinical exam, apnea test, ancillary tests</image>

Section 10: Ethical Considerations in Neurocritical Care

Surrogate decision-making is a fundamental ethical framework in neurocritical care, where patients are frequently unable to participate in their own medical decisions due to impaired consciousness. The preferred standard is substituted judgment, in which the surrogate attempts to determine what the patient would have wanted based on their known values, previously expressed preferences, and prior conversations about medical care. When the patient's preferences are unknown and no prior statements are available, the surrogate and medical team apply the best interest standard, making decisions based on what a reasonable person in the patient's circumstances would be expected to want. The legal hierarchy of surrogate decision-makers typically proceeds from spouse to adult children to parents and then to other family members, though this hierarchy varies by jurisdiction. Advance directives, including living wills and durable power of attorney for healthcare documents, should be sought and honored, as they represent the most direct expression of the patient's autonomous wishes.

The withdrawal of life-sustaining therapy is an ethically and legally accepted practice when continued treatment is inconsistent with the patient's wishes or when it constitutes medical futility, meaning that treatment cannot reasonably be expected to achieve the goals of care. The concept of medical futility recognizes that there are circumstances in which continued aggressive treatment will not reverse the underlying condition or produce a meaningful recovery and may only prolong the dying process. The patient's values and previously expressed wishes must guide these decisions, ensuring that the care provided aligns with what the patient would have wanted rather than what the medical team or family prefers. Family meetings, conducted by experienced clinicians with clear, empathetic communication, are essential for shared decision-making and should provide the family with an honest assessment of the prognosis while supporting their emotional needs. When a decision is made to transition to comfort measures, the focus shifts entirely to ensuring a dignified death with adequate symptom management, including treatment of pain, dyspnea, and agitation.

Communicating prognosis in neurocritical care requires balancing honesty about the severity of the situation with acknowledgment of the inherent uncertainty that accompanies neurological prognostication. Honesty demands that the clinician communicate the prognosis clearly and directly, avoiding euphemisms that may create false hope or obscure the gravity of the situation, while also being transparent about the limitations of prognostic tools and the degree of uncertainty involved. Timing is critical, as prognostic assessments made too early may be inaccurate, particularly after cardiac arrest or traumatic brain injury, where an appropriate waiting period is necessary before reliable prognostic information can be obtained. A multimodal approach using multiple independent data points, including clinical examination, neuroimaging, electrophysiology, and biomarkers, provides the most reliable prognostic assessment. The clinician must also assess the family's understanding and address common misconceptions about brain injury and recovery, as families frequently overestimate the likelihood and extent of recovery.

Organ donation is an important consideration in the neurocritical care setting and requires sensitive, ethically sound management that respects the dignity of the dying patient while recognizing the potential to save other lives. Donation after brain death is the most common pathway and follows the formal declaration of death by neurological criteria. Donation after circulatory death is an alternative pathway for patients who do not meet brain death criteria but in whom a decision has been made to withdraw life-sustaining therapy. Early involvement of the organ procurement organization is recommended, as they can assist with donor evaluation and family communication. The discussion of organ donation with the family should be conducted by personnel who are separate from the primary care team to avoid any perception of conflict of interest, and families should be supported throughout the process regardless of their decision.

<image>Ethics: surrogate decisions, withdrawal, prognosis, donation</image>

Summary

• GCS: E4V5M6 = 15; GCS ≤8 = severe TBI, intubate
• Pupil findings: unilateral dilation = herniation until proven otherwise
• ICP management: head elevation, sedation, osmotic therapy, CSF drainage, surgery
• Mannitol: osmotic diuresis; monitor osmolality; avoid hypotension
• Hypertonic saline: maintains volume; target Na 145-155
• Uncal herniation: ipsilateral dilated pupil + contralateral hemiparesis
• Severe TBI targets: ICP <22, CPP 60-70, SBP >100-110, normothermia
• SAH: vasospasm days 3-14; nimodipine; secure aneurysm early
• NCSE: altered mental status in ICU; continuous EEG to diagnose
• Brain death: irreversible coma, absent brainstem reflexes, positive apnea test

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown